Wellington Management Group LLP Trims Stock Position in Chemed Co. (NYSE:CHE)

Wellington Management Group LLP lowered its holdings in Chemed Co. (NYSE:CHE - Free Report) by 95.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,242 shares of the company's stock after selling 65,275 shares during the quarter. Wellington Management Group LLP's holdings in Chemed were worth $1,948,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CHE. Thrivent Financial for Lutherans boosted its holdings in Chemed by 300.3% during the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company's stock worth $63,249,000 after buying an additional 87,449 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Chemed during the 3rd quarter worth about $437,150,000. Impax Asset Management Group plc grew its position in shares of Chemed by 19.5% during the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company's stock valued at $172,510,000 after acquiring an additional 51,974 shares during the period. FMR LLC grew its position in shares of Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock valued at $143,401,000 after acquiring an additional 45,917 shares during the period. Finally, Epoch Investment Partners Inc. increased its stake in shares of Chemed by 22.1% in the 2nd quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company's stock valued at $121,068,000 after purchasing an additional 40,358 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Price Performance

Chemed stock traded up $3.20 during midday trading on Thursday, reaching $521.79. The company had a trading volume of 139,238 shares, compared to its average volume of 86,796. Chemed Co. has a 12-month low of $516.91 and a 12-month high of $654.62. The company has a market capitalization of $7.85 billion, a P/E ratio of 26.37, a P/E/G ratio of 2.32 and a beta of 0.46. The firm's fifty day simple moving average is $567.08 and its 200-day simple moving average is $564.37.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. During the same period in the prior year, the firm earned $5.32 earnings per share. The business's revenue was up 7.4% on a year-over-year basis. On average, analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend was Monday, November 18th. Chemed's dividend payout ratio (DPR) is 10.11%.

Insider Transactions at Chemed

In other Chemed news, Director George J. Walsh III sold 400 shares of the company's stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This represents a 11.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the firm's stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares of the company's stock, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,132 shares of company stock valued at $3,003,502. Corporate insiders own 3.32% of the company's stock.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of recent analyst reports. Royal Bank of Canada lowered their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.